Actress Kat Graham using Vital Red Light’s ‘Vital Pro’ device

Red light therapy, also known as photobiomodulation (PBM), has been around for nearly 50 years after it was pioneered by NASA scientists.

LOS ANGELES (PRWEB)
November 08, 2021

Vital Red Light, a leader in the personal light therapy market, announces a new collection of at-home, professional grade red and near-infrared light therapy devices. With the launch of Vital Red Light, millions of people worldwide will have access to improve their health and well-being, right at-home. This new line from Vital Red Light is the first of many at-home wellness products being developed by the startup company in the health technology & wellness sector.

Red light therapy, also known as photobiomodulation (PBM), has been around for nearly 50 years after it was pioneered by NASA scientists. Since then, red light therapy has been used by the world’s leading dermatologists, wellness experts, and professional athletes to provide a wide range of health benefits. With the release of Vital Red Light’s at-home red and near-infrared (NIR) light therapy devices, customers can now benefit from a medical-grade experience, in the comfort of their own home.

“NASA scientists, professional athletes, and forward thinking health experts have been using red light therapy for a very long time”, says Vital Red Light Founder and CEO Jake Kreuz. “The launch of Vital Red Light gives anybody access to professional-grade red light therapy treatments in the comfort of their own home. With the ongoing pandemic and the new normal of working from home, we want our customers to have access to the most innovative natural health modalities during a time when people need it the most. We are just getting started as we continue to develop products that can further help people feel better, naturally.”

Vital Red Light Reference Video:

https://drive.google.com/file/d/1te3ji-nvB4mwlBEPe0sueFwnvtwwy07S/view?usp=sharing

Vital Red Light is already a favorite among Olympic and professional athletes, Hollywood celebrities, trainers, beauty professionals, and wellness clinics around the world. The company continues to sell devices across the world with overwhelmingly positive feedback. Red light therapy has been shown to be a noninvasive, non-toxic, beneficial healing modality.

“Once you integrate Vital Red Light into your daily routine, it is literally life-changing. I use the device in the morning, and the energy received literally substitutes the need for coffee, and then right before bed, which allows my mind and body to immediately relax, for an immediate transition into sleep. The results are remarkable, and our mission is to bring this awareness and technology to consumers worldwide.” – Investor, Oliver Trevena

The brand already has many celebrity fans such as Jenna Dewan, Nikki Reed, Brooke Burke, and it’s new official ambassador, Kat Graham. https://www.instagram.com/p/CV8SWS5Dqf6/?utm_medium=copy_link

About Red Light Therapy

Red light therapy involves exposing the body to red and near-infrared wavelengths of light. Light at certain wavelengths has been scientifically proven to interact with the body in beneficial ways. Red light therapy, comprising both red and near-infrared wavelengths, is a uniquely healing part of the electromagnetic spectrum and it is one of the most natural ways to charge the body to rejuvenate and repair. This has been demonstrated by peer-reviewed studies, including research at NASA.

How Red Light Therapy Works

Red and near-infrared wavelengths of light from a light therapy device penetrate the skin and work in particular on the cell’s mitochondria, which is also known as the cell’s main energy producer. In various clinical studies, the cytochrome c-oxidase in the mitochondria absorbs red light, which causes the release of nitric oxide, furthering the production of ATP and reducing oxidative stress. ​​Red light therapy has been shown to produce a wide range of natural health benefits including: reducing inflammation & pain, reducing recovery time and muscle soreness, improving sleep, stimulating hair regrowth, and naturally enhancing collagen levels in the skin.

About Vital Red Light

Vital Red Light is one of the world’s most trusted manufacturer of premium red and near infrared light therapy devices. The Company makes powerful, professional-grade light therapy treatments affordable and accessible for everyone to use. Today, Vital Red Light therapy devices are being used by thousands of individuals across the world to improve their health in the comfort of their own home. Professional athletes, medical professionals (dermatologist, chiropractors, sports medicine, aestheticians, and world-class gyms & health clinics all trust Vital Red Light as their source for red light therapy devices. Vital Red Light is pioneering the next wave of innovative and empowering health technology.

Visit https://vitalredlight.com/pages/why-use-red-light-therapy/ for more information on Red Light Therapy and to shop and explore the Vital Red Light device collection.

Follow on social media @VitalRedLight for up to date information, tips and learnings.

Share article on social media or email:

Joe Simone

“We are seeing the proliferation of free-standing emergency rooms, healthcare monitoring apps, home health devices, and even classic house calls,” said Joe Simone. “All these services are designed to satisfy the growing demand for convenient care.”

BRONX, N.Y. (PRWEB)
November 08, 2021

Competition to deliver the most convenient care is a factor in recent announcements about new medical real estate projects, says Joe Simone, President of Simone Development Companies.

Across the United States, hospital networks are unveiling proposals that consolidate offices and services in easy-to-access locations to attract patients who have grown accustomed to appointment-free urgent care and telehealth.

“In October, Mount Sinai Morningside filed plans for a $28.5 million outpatient clinic in New York City’s Harlem neighborhood that consolidates primary care, surgical services, and AIDS outpatient health from several other locations with the goal of integrating care and reducing inefficiency,” said Joe Simone, President of Simone Development Companies. “Similarly, UChicago Medicine recently announced a hospital in northwest Indiana. Again, the goal is to deliver a seamless experience to patients who need convenient access to advanced care.”

Simone Development Companies is a leader in the push for convenient healthcare with the development of the Hutchinson Metro Center, a 42-acre mixed-use campus in the Bronx that combines an ambulatory surgical center with retail, hospitality, office, and doctors’ offices.

“Bronx residents can receive every aspect of their health care at the Hutchinson Metro Center,” said Joe Simone. “The old, fragmented model of health care where a primary care doctor and a specialist were miles apart in a congested city didn’t work for many Bronx residents, who prefer an integrated campus with ample parking and easy access to public transportation.”

Another example is Simone Development’s Boyce Thompson Center in Yonkers, NY, an 85,000-square-foot mixed-use center featuring medical offices, retail shops and restaurants. Major anchor tenants include St. John’s Riverside Hospital and Westmed Medical Group.

Joseph Simone said that recent announcements about new hospitals and consolidated facilities are just one aspect of the emerging convenience care trend.

“We are seeing the proliferation of free-standing emergency rooms, healthcare monitoring apps, home health devices, and even classic house calls,” said Joe Simone. “All these services are designed to satisfy the growing demand for convenient care.”

Simone Development Companies is a fully integrated private real estate investment and development company that acquires and develops healthcare, mixed-use, commercial, industrial, retail and residential properties. Headquartered at the Hutchinson Metro Center, it boasts a portfolio of over seven million square feet throughout the Bronx, Manhattan, Queens, Long Island, Westchester, Orange and Fairfield Counties and New Jersey. With services spanning acquisition, development, construction, finance, asset management, accounting, leasing and property management, Simone Development Companies is set apart by its creatively oriented management team, long-term asset ownership and its pursuit of visionary development.

Share article on social media or email:

“As a privately held company, we are proud to deliver benefits many companies will not – paid parental leave, adoption assistance, fair compensation, opportunities for development and sharing in our successes are all a part of that.”

ST. LOUIS (PRWEB)
November 08, 2021

At a time when Veterinarians are overworked, underappreciated and plagued with compassion fatigue, CareVet launched The Ultimate CarePackage, a suite of innovative DVM benefits aimed at providing doctors with the personal and professional support and security they deserve.

In addition to their industry leading DVM benefits package and highly competitive compensation and signing bonuses, Veterinarians joining CareVet will benefit from industry first programs including student loan support, up to 8 weeks of paid parental leave, adoption assistance, paid time off at its exclusive Carebnb vacation properties, comprehensive EAP with an on-site licensed social worker and much more.

This is all part of CareVet’s continuing effort to revolutionize the veterinary industry as it grows its network to more than 100 veterinary hospitals operating in more than 30 states, with more than 1,500 Team Members, 334,000 patients and 210,000 clients.

According to CEO Greg Siwak, “Great medicine starts with great teams, which is why attracting and retaining top talent is one of CareVet’s top priorities. We understand that without outstanding Team Members we can’t provide the best level of care or serve as many pets in our community. We are constantly striving to lead the industry and improve the standards for all animal health professionals. As a privately held company, we are proud to deliver benefits many companies will not – paid parental leave, adoption assistance, fair compensation, opportunities for development and sharing in our successes are all a part of that.”

Co-founder Kent Thornberry, DVM, said in a recent letter to the company, “Building a best-in-class benefits program is a journey, not a destination. We’ll never stop innovating ways to invest in you, including your health, support, fulfillment and advancement needs. That is why I am excited to announce our new suite of DVM benefits to be offered over the next few months.”

CareVet’s 96% DVM retention rate, 12% greater than the industry average, demonstrates its ongoing commitment to listening to its Team Members and supporting their wellbeing, positioning the company as an employer of choice. As part of its expansion efforts, CareVet announced the following new initiatives:

Strong Start Program for New DVMs

• $100,000 Minimum Base Salary: We offer our full-time DVMs a minimum base salary of $100,000 with no negative accrual and production bonuses.
• Signing Bonuses: We provide generous signing bonuses to DVMs in addition to our highly competitive compensation package.
• Student Loan Support: Apply signing bonus dollars pre-tax to student loan debt up to $5,250 per year.
• Child & Dependent Care: Apply signing bonus dollars pre-tax to child and dependent care costs up to $5,000 per year.
• No Upfront Non-Competes: We’re so confident DVMs will love working with CareVet, we do not require a non-compete for the first six months after signing.
• Mentorship-Driven Experience: New DVMs will be paired with experienced CareVet Veterinarians with similar areas of expertise and passion.

Whole Person Support

• EAP with On-Staff Social Worker: In addition to CareVet’s comprehensive Employee Assistance Program, CareVet has their new Team Member Care Program, giving CareVet DVMs access to an on-staff licensed social worker.
• Company-Paid Short-Term Disability: CareVet’s Short-Term Disability plan pays DVMs 60% of weekly wages directly (up to $1,500) in the event they are temporarily disabled and unable to work.
• Company-Paid Life Insurance: CareVet offers DVMs life insurance at 1.5x salary (up to $100,000), boosting a DVM’s financial security and giving peace of mind.

Parental Support

• Paid Parental Leave: CareVet DVMs receive up to 8 weeks of fully paid parental leave to ensure they are supported as they become new parents.
• Adoption Assistance: CareVet offers up to $10,000 to assist with the adoption of a child to support our DVMs in growing their family.

Work/Life Balance

• Schedule Flexibility: CareVet offers schedule flexibility with the option to work full-time or part-time, allowing Veterinarians to take control of their schedule.
• Paid Time Off: CareVet encourages our DVMs to take their hard-earned time off. With paid time off, they can rest, relax and recharge knowing their hospital is supported.
• Carebnb: When planning vacation, CareVet DVMs can take advantage of Carebnb – a selection of vacation properties at a variety of relaxing locations.

Community Giveback

• Charity Match: CareVet’s charity match program is dedicated to giving back to the communities DVMs call home with donations up to $500 to nonprofit organizations per year per DVM.
• Volunteer Opportunities: CareVet empowers hospitals to give back to their community. CareVet supports DVMs with fundraising, strategic local partnerships, donations and designated volunteer opportunities.

CareVet Veterinarians also benefit from many of the incredible resources offered to all Team Members, from outstanding mental health support to continuing education focused on personal and professional growth. The CareVet Whole Person Approach results in its teams feeling more empowered, allowing them to deliver a superior level of care to patients. These benefits include:

• Living Wage Initiative: CareVet offers industry-leading wages for veterinarian Team Members at $15 an hour, empowering our employees with a strong financial foundation.
• Revenue-Sharing Program: All hospital Team Members participate in our Revenue-Sharing Program, allowing teams to become invested in their work at CareVet at a local level.
• Skills & Development: CareVet Learning Institute encompasses a curriculum of customized learning paths, RACE approved courses and leadership and skill development opportunities.
• State-of-the-Art Facilities: CareVet has committed to investing $75 million to the improvement of its facilities over the next five years.

For more on CareVet’s initiatives for attracting and retaining the industry’s best Veterinarians, visit carevethealth.com/what-we-offer/veterinarians.

###

About CareVet: CareVet is an industry leading network of veterinary hospitals operating in 30+ states with more than 1,500 Team Members. Founded in 2018 by Dr. Kent Thornberry, a DVM who built and grew two of his own veterinary hospitals before selling them to two separate veterinary practice management groups and Greg Siwak, a highly regarded entrepreneur. Together, they felt there was a better operating model for hospitals anchored in a deep commitment and investment in the teams that service their clients and pets. CareVet is privately held and headquartered in St. Louis, Missouri, and can be visited at CareVetHealth.com and followed on LinkedIn at @CareVet-Health and Facebook at @CareVetHealth.

Share article on social media or email:

“For almost 20 years, we’ve provided modern treatment approaches. Clinical trials give us the ability to offer more care options to patients while contributing to the research and development of next-generation dermatology therapies, medical devices, and treatment processes.” – Jennifer Alberts, MD

GRAND ISLAND, Neb. (PRWEB)
November 08, 2021

Meridian Clinical Research, a leading multi-specialty investigative research site network is partnering with Grand Island Dermatology, a physician-owned group practice providing comprehensive and high-quality medical care to children, adolescents, and adults. The research site will be located within the Grand Island Dermatology office at 418 N. Webb Road in Grand Island, NE 68803.

Susan Corey, MD and Jennifer Alberts, MD will serve as principal investigators to conduct clinical trials related to dermatology for people of all ages. Dr. Alberts and Dr. Corey are both diplomates of the American Board of Dermatology and active members of the American Academy of Dermatology, the American Society of Dermatologic Surgery, and the Nebraska Medical Association.

Nicole Osborn, Founder and CEO of Meridian, said the company looks forward to bring dermatological clinical trials to Central Nebraska. “As we establish more locations throughout the state, it enables us to bring more therapeutically specialized trials — like dermatology studies — to patients seeking care for skin disorders,” said Osborn. “We look forward to partnering with Dr. Alberts and Dr. Corey, who are leading specialists and highly regarded across their region, well beyond Grand Island.”

“For almost 20 years, we’ve provided modern treatment approaches,” said Dr. Alberts. “Clinical trials give us the ability to offer more care options to patients while contributing to the research and development of next-generation dermatology therapies, medical devices, and treatment processes. Clinical trials can be particularly helpful for people who have rare or severe skin diseases that don’t respond well to currently available therapies.”

The site will be Meridian’s third in Grand Island, and follows the company’s opening of a dedicated research center in the city. Since opening in Omaha in 1999, Meridian has grown to 30 sites nationwide and enrolled more than 80,000 patients in 3,400 clinical trials. In 2020, the company began conducting COVID-19 vaccine clinical trials in Grand Island and nationwide. These trials were for the COVID-19 mRNA vaccines that have received Emergency Use Authorizing and/or approval.

If you’re interested in joining a clinical trial at Meridian, or want to sign up to learn about upcoming studies, visit mcrmed.com/find-study. For more information about careers at Meridian and current openings in Grand Island, visit mcrmed.com/careers.

ABOUT MERIDIAN CLINICAL RESEARCH

Meridian Clinical Research, partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is a multi-specialty site network headquartered at its dedicated research center in Omaha, NE, and conducts Phase 1-4 studies at investigative sites nationwide. Meridian supports research across numerous therapeutic areas and excels in high-volume vaccine trials. For more information, visit mcrmed.com.

Share article on social media or email:

“Access to clinical trials is access to healthcare. To ensure the comfort level of diverse communities in clinical research, we need to increase the diversity of individuals working within all facets of healthcare as a whole,” said Melissa Hardman, Founder & CEO, Faces of Research LLC.

Boston (PRWEB)
November 08, 2021

The Center for Information and Study on Clinical Research Participation (CISCRP), a non-profit organization dedicated to educating and informing the public about the clinical research process, announced today its AWARE for All-Atlanta Forum. This is a free, virtual event that is open to the public and will be held November 16th-18th, from 6-7pm EST each night. The forum is tailored for the Atlanta community, featuring local clinical trial participants, healthcare professionals, and organizations.

In an effort to reduce health disparities and increase demographic diversity in clinical trials, the forum brings together a unique consortium of health educators and clinical trial participants who will share the benefits of clinical research and the important role trials play in advancing healthcare. To register for the Atlanta event visit: https://www.ciscrp.org/event/aware-for-all-atlanta-virtual-event/.

The COVID-19 pandemic’s disproportionate impact on communities of racial and ethnic minorities, combined with decades of distrust and misinformation about clinical research, has raised the urgency to broaden outreach to reach more participants in clinical trials. The AWARE for All forum aims to increase participation by historically marginalized communities that have long been absent from research for treatments, vaccines, medical devices, and therapeutic drugs.

“Research should be the next step in the healthcare process, not a daunting process. Access to clinical trials is access to healthcare. To ensure the comfort level of diverse communities in clinical research, we need to increase the diversity of individuals working within all facets of healthcare as a whole,” said Melissa Hardman, Founder & CEO, Faces of Research LLC.

AWARE for All – Atlanta is supported by local research teams, advocacy groups, and a consortium of biopharmaceutical and service provider companies. The program will answer key questions about the clinical trials process, what to expect as a participant, and the benefits and risks of participation. This 3-night webinar series will feature multiple panel discussions, including perspectives from clinical trial participants and healthcare professionals:

Tina Berry, Breast Cancer Trial Participant

Terp Varin, Mental Health Trial Participant

Glenn Bachman, Lymphoma Cancer Trial Participant

Ashley Nealy, COVID-19 Vaccine Trial Participant

Phyllis Kaplan, Type 1 Diabetes Trial Participant

Mary Slomkowski, Otsuka

Leah Szumita, Leukemia & Lymphoma Society

Meghan McKenzie, Genentech

Adaline Kumar, CureQuest LLC

Zach Mitchel, iResearch Atlanta

Tamara Wakhisi, Northside Hospital-Central Research Department

Melissa Hardman, Faces of Research, LLC

Yolanda Little, Novartis

The AWARE for All event series has been crucial in driving attention to clinical research via common medical conditions, with a goal of reaching a diverse population to advance research and quality of care. It is the fifth of the 2021 AWARE for All programs.

As part of the virtual event, an Informational Exhibit Center will feature over 30 organizations sharing resources, a Health & Wellness pavilion, and a theater with short educational videos about clinical trials. Exhibitors include Pfizer, Biogen, Janssen, Otsuka, IQVIA, CSL Behring, EMD Serono, WCG, Novartis, and Genentech. Visitors can also connect with Atlanta-based organizations such as SisterLove, RedMoon Project, iResearch Atlanta, Georgia Ovarian Cancer Alliance, Diabetes Association of Atlanta, and many more.

To access earlier 2021 AWARE for All recorded webinars and Informational Exhibit Centers, visit http://www.awareforall.org.

About CISCRP

The Center for Information and Study on Clinical Research Participation (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. CISCRP provides free education and outreach to the general public and patient communities.

Visit http://www.CISCRP.org  for more information or to participate in CISCRP’s educational initiatives. For additional questions about AWARE for All, contact awareforall@ciscrp.org or call 877-633-4376.

Share article on social media or email: